Bile duct cancer is classified by location: intrahepatic, perihilar, or distal, influencing symptoms and treatment options. Diagnosis involves blood tests, imaging, endoscopic procedures, and biopsy ...

There is an association between hepatitis B virus (HBV) infection and an increased risk of extrahepatic bile duct cancer. The extrahepatic bile duct collects bile from the liver, but is located ...

Bile duct cancer, also known as cholangiocarcinoma, forms in the thin tubes that carry bile from your liver to your gallbladder and small intestine. Though relatively rare, cholangiocarcinoma is often ...

Bile duct cancer can often be treated more effectively when detected early. However, its initial symptoms are often mild and can resemble common digestive or liver problems, leading to delayed ...

In 2023, Sydney Towle, then 23, developed a bump on her abdomen that she could feel. When she exercised, she experienced a stinging in her stomach. Worried that she developed a hernia, Towle visited ...

Perineural invasion may help refine risk assessment in intrahepatic bile duct cancer. Find out what this meta-analysis means ...

The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid improvements in diagnosis, treatment and research for cholangiocarcinoma, also ...

Dr. Shaun P. McKenzie discusses bile duct cancer challenges and why awareness and specialized care help patients get diagnosed earlier and live longer. During Gallbladder and Bile Duct Cancer ...

The influencer, 26, is currently in between stages of a clinical trial involving tumor-infiltrating lymphocyte therapy ...

Drugs designed to target HER2-postive breast cancer could also benefit some patients with bile duct cancer, according to results of a patient trial to be presented on Thursday at the 36th ...

Gallbladder cancer and cholangiocarcinoma are different types of biliary tract cancer. They affect the same system in the body and cause similar symptoms, but they may require different treatments.

Drugs that target advanced breast cancer could help patients with a rare cancer that affects parts of the digestive system, a trial has found. Tucatinib and trastuzumab work by blocking a protein ...